Boronated protoporphyrin (BOPP): Localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 3, 1999, Pages 761-771

  Callahan, Daniel E ^a   Forte, Trudy M ^a   Javed Afzal, S M ^a   Deen, Dennis F ^b   Kahl, Stephen B ^b   Bjornstad, Kathleen A ^a   Bauer, William F ^c   Blakely, Eleanor A ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c IDAHO NATIONAL LABORATORY   (United States)

Author keywords

BOPP; Boron neutron capture therapy; Brain tumors; LDL receptor; Porphyrins

Indexed keywords

BORONATED PROTOPORPHYRIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; FLUORESCENCE MICROSCOPY; GLIOMA CELL; HUMAN; HUMAN CELL; LYSOSOME; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL;

NON-PROGRAMMATIC;

ANTINEOPLASTIC AGENTS; BORON COMPOUNDS; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOBLASTOMA; HUMANS; LIPOPROTEINS; LYSOSOMES; MICROSCOPY, FLUORESCENCE; PROTOPORPHYRINS; RECEPTORS, LDL; TUMOR CELLS, CULTURED;

EID: 0032824173     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00172-8     Document Type: Article

References (51)

1. Hill J.S., Kahl S.B., Kaye A.H., et al. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci USA. 89:1992;1785-1789.
2. Kahl S.B., Koo M.-S. Synthesis of tetrakis-carborane carboxylate esters of 2,4-di(α,β-dihydroxyethyl)-deuteroporhyrin IX. J Chem Soc Chem Commun. 24:1990;1769-1771.
3. Coderre J.A., Morris G.M. The radiation biology of boron neutron capture therapy. Radiat Res. 151:1999;1-18.
4. Soloway A.H., Tjarks W., Barnum B.A., et al. The chemistry of neutron capture therapy. Chem Rev. 98:1998;1515-1562.
5. Laramore G.E., Spence A.M. Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain A cautionary note . Int J Radiat Oncol Biol Phys. 36:1996;241-246.
6. Bartelink H., Mijnheer B., Dewit L. Is there a future for neutron capture therapy? Int J Radiat Oncol Biol Phys. 36:1996;267-268.
7. Barth R.F., Soloway A.H., Brugger R.M. Boron neutron capture therapy of brain tumors Past history, current status, and future potential . Cancer Invest. 14:1996;534-550.
8. Dorn R.V. Boron neutron capture therapy (BNCT) A radiation oncology perspective . Int J Radiat Oncol Biol Phys. 28:1994;1189-1201.
9. Barth R.F., Soloway A.H., Fairchild R.G., et al. Boron neutron capture therapy for cancer Realities and prospects . Cancer. 70:1992;2995-3007.
10. Nguyen T., Brownell G.L., Holden S.A., et al. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations. Radiat Res. 133:1993;33-40.
11. Barel A., Jori G., Perin A., et al. Role of high-, low-, and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo. Cancer Lett. 32:1986;145-150.
12. Jori G. In vivo transport and pharmacokinetic behaviour of tumor photosensitizers. In Photosensitizing compounds: Their chemistry, biology, and clinical use . Ciba Found Symp. 146:1989;78-94.
13. Kessel D., Luo Y. Delayed oxidative photodamage induced by photodynamic therapy. Photochem Photobiol. 64:1996;601-604.
14. Maziere J.C., Morliere P., Santus R. The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumors. J Photochem Photobiol B. 8:1991;351-360.
15. Allison B.A., Pritchard P.H., Levy J.G. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. Br J Cancer. 69:1994;833-839.
16. Geze M., Morliere P., Maziere J.C., et al. Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications. J Photochem Photobiol B. 20:1993;23-35.
17. Kessel D. Porphyrin-lipoprotein association as a factor in porphyrin localization. Cancer Lett. 33:1986;183-188.
18. Goldstein J.L., Brown M.S. The low-density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem. 46:1977;897-930.
19. Wong J.R., Ho C., Mauch P., et al. Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123. Clin Cancer Res. 1:1995;621-630.
20. Basu H.S., Pellarin M., Feuerstein B.G., et al. Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines. Cancer Res. 53:1993;3948-3955.
21. Goldstein J.L., Basu S.K., Brown M.S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98:1983;241-260.
22. Bauer W.F., Johnson D.A., Steele S.M., et al. Gross boron determination in biological samples by inductively coupled plasma-atomic emission spectroscopy. Strahlenther Onkol. 165:1989;175-179.
23. Mascio L.N., Verbeek P.W., Kuo W.-L., et al. Semi-automated DNA probe mapping using digital imaging microscopy. I. System development. Cytometry. 19:1995;51-59.
24. Mulliken J.C., van Vliet L.J., Netten H., et al. Methods for CCD camera characterization. Titus H.C., Waks A. Proceedings SPIE Image Acquisition and scientific imaging systems . 1994;73-84 SPIE-The International Society for Optical Engineering, Bellingham, WA.
25. Davis S., Weiss M.J., Wong J.R., et al. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem. 260:1985;13844-13850.
26. Wong J.R., Chen L.B. Recent advances in the study of mitochondria in living cells. Adv Cell Biol. 2:1988;263-290.
27. Woodburn K.W., Vardaxis N.J., Hill J.S., et al. Subcellular localization of porphyrins using confocal laser scanning microscopy. Photochem Photobiol. 54:1991;725-732.
28. Rashid F., Horobin R.W., Williams M.A. Predicting the behaviour and selectivity of fluorescent probes for lysosomes and related structures by means of structure-activity models. Histochem J. 23:1991;450-459.
29. Moan J., Berg K., Kvam E., et al. Intracellular localization of photosensitizers. Photosensitizing compounds their chemistry, biology, and clinical use . Ciba Found Symp. 146:1989;95-111.
30. Forte T.M., Bell-Quint J.J., Cheng F. Lipoproteins of fetal and newborn calves and adult steer A study of developmental changes . Lipids. 16:1981;240-245.
31. Chadha M., Capala J., Coderre J.A., et al. Boron neuron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory. Int J Radiat Oncol Biol Phys. 40:1998;829-834.
32. Hatanaka H., Nakagawa Y. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys. 28:1994;1061-1066.
33. Nakagawa Y., Hatanaka H. Boron neutron capture therapy Clinical brain tumor studies . J Neurooncol. 33:1997;105-115.
34. Madoc-Jones H., Zamenhof R., Solares G., et al. A phase-I dose escalation trial of boron neutron capture therapy for subjects with metastatic subcutaneous melanoma of the extremities. Mishima Y. Cancer neutron capture therapy. 1996;707-716 Plenum Press, New York.
35. 10B-neutron capture therapy Enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluation . Int J Radiat Oncol Biol Phys. 11:1985;831-840.
36. Kabalka G.W., Smith G.T., Dyke J.P., et al. Evaluation of fluorine-18-BPA fructose for boron neutron capture treatment planning. J Nucl Med. 38:1997;1762-1767.
37. Imahori Y., Ueda S., Ohmori Y., et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med. 39:1998;325-333.
38. Bauer W.F., Bradshaw K.N., Richards T.L. Interaction between boron containing compounds and serum albumin observed by nuclear magnetic resonance. Allen B.J., Harrington B.V. In Progress in neutron capture therapy for cancer . 1992;339-343 Plenum Press, New York.
39. Soloway A.H., Hatanaka H., Davis M.A. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J Med Chem. 10:1967;714-717.
40. Gabel D., Preusse D., Haritz;, et al. Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumors as prerequisite for a phase I clinical trial of boron neutron capture. Acta Neurochir. 139:1997;606-612.
41. Ceberg C.P., Brun A., Kahl S.B., et al. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. J Neurosurg. 83:1995;86-92.
42. Ozawa T., Afzal J., Wyrick B.J., et al. In vivo evaluation of a boronated porphyrin in malignant glioma models. (Abstr.) Proc Am Assoc Cancer Res. 39:1998;586.
43. Tibbitts J., Fike J.R., Lamborn K.L., et al. Toxicology of a boronated porphyrin in dogs. Photochem Photobiol. 69:1999;587-594.
44. Pisoni R.L., Thoene J.G. The transport systems of mammalian lysosomes. Biochem Biophys Acta. 1071:1991;351-373.
45. Spizzirri P.G., Hill J.S., Kahl S.B., et al. Photophysics and intracellular distribution of a boronated porphyrin phototherapeutic agent. Photochem Photobiol. 64:1996;975-983.
46. Berg K., Moan J. Lysosomes and microtubules as targets for photochemotherapy of cancer. Photochem Photobiol. 65:1997;403-409.
47. Crompton NEA, Walt H, Kahl SB; et al. Neutron capture (NCT) and photodynamic therapy (PDT) with a single compound: Boronated protoporphyrin (BOPP). In: Hawthorne MF, Wiersema R, Shelly K, editors. Frontiers in neutron capture therapy. New York: Plenum Publishing Corp. (In press).
48. Korbelik M., Hung J., Lam S., et al. The effects of low density lipoproteins on uptake of Photofrin II. Photochem Photobiol. 51:1990;191-196.
49. Allison B.A., Pritchard P.H., Richter A.M., et al. The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution. Photochem Photobiol. 52:1990;501-507.
50. Allison B.A., Waterfield E., Richter A.M., et al. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol. 54:1991;709-715.
51. Kahl S.B., Callaway J.C. New tumor localizers Advances in the use of low density lipoproteins (LDL) . Strahlenther Onkol. 165:1989;137-139.